From Name:
From Email:
To Name:
To Email:

Optional Message:

Myriad gene patent ruling triggers race for cancer tests

from Bloomberg

Companies and a university are moving to offer cheaper and broader genetic testing for breast cancer risk to a growing group of women, following a U.S. Supreme Court ruling that ended Myriad Genetics Inc.'s monopoly over DNA that vastly raises odds for the disease. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063